Apollomics Inc. announced that on January 16, 2024, it received a notification from The Nasdaq Stock Market LLC stating that the company is not in compliance with the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the company’s Class A ordinary shares, par value $0.0001 per share, was below $1.00 per share for 30 consecutive business days. The Notice has no immediate effect on the listing of the Ordinary Shares, and the Ordinary Shares continue to trade on the Nasdaq Capital Market under the symbol “APLM.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on APLM:
- Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
- Apollomics completes enrollment in Phase 3 bridging study of APL-106
- Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
- Apollomics to Present at the 2024 Biotech Showcase